Future for VHL kidney cancer is bright
Von Hippel-Lindau (VHL) disease–associated renal cell carcinoma (RCC) has always [...]
Nephritis as a potential predictor of response to immune checkpoint inhibitors in kidney cancer
This study, to be published in Journal for Immunotherapy of [...]
γ-Glutamyltransferase as a biomarker in patients on nivolumab for metastatic kidney cacner
A protein called γ-glutamyltransferase can predict survival in patients with [...]
Cryoablation versus partial nephrectomy for T1 kidney tumours
In this study published in Science Direct, the researchers compared [...]
Cancer52: CEO Meeting
Sharon Kell attended the Cancer52 Chief Executive Officer's meeting in [...]
ABPI Patient Organisation Forum
Sharon Kell rang in to this virtual meeting to discuss [...]
PDIGREE trial: Ipilimumab plus nivolumab with cabozantinib for untreated advanced kidney cancer
During this video interview from UroToday, Dr Tian Zhang from [...]
COVID-19: Cancer screening programmes return to normal?
Oncologists have learnt many lessons during the first wave of [...]
The flu vaccination programme during the COVID-19 pandemic
The Government have released guidance on delivering the flu vaccination [...]
UK Government’s Vaccine Taskforce
The UK Government has set up the Vaccine Taskforce; a [...]
